Elevation Point Wealth Partners LLC Invests $533,000 in National HealthCare Corporation $NHC

Elevation Point Wealth Partners LLC acquired a new stake in shares of National HealthCare Corporation (NYSEAMERICAN:NHC) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 2,516 shares of the company’s stock, valued at approximately $533,000.

A number of other large investors also recently bought and sold shares of NHC. BlackRock Inc. purchased a new stake in National HealthCare during the second quarter worth $417,602,000. Morgan Stanley Institutional Investment Advisors LLC increased its holdings in shares of National HealthCare by 38.6% in the 4th quarter. Morgan Stanley Institutional Investment Advisors LLC now owns 1,038,787 shares of the company’s stock valued at $142,407,000 after acquiring an additional 289,566 shares during the period. First Trust Advisors LP increased its holdings in shares of National HealthCare by 45.4% in the 1st quarter. First Trust Advisors LP now owns 530,302 shares of the company’s stock valued at $84,689,000 after acquiring an additional 165,615 shares during the period. Geode Capital Management LLC raised its position in shares of National HealthCare by 0.7% in the 4th quarter. Geode Capital Management LLC now owns 318,440 shares of the company’s stock worth $43,662,000 after acquiring an additional 2,361 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new stake in shares of National HealthCare during the 2nd quarter worth $25,854,000. Institutional investors own 56.44% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on NHC shares. BMO Capital Markets raised National HealthCare to a “hold” rating in a research report on Monday, May 18th. Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a report on Monday, May 18th. The Goldman Sachs Group raised shares of National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, Robert W. Baird upgraded shares of National HealthCare to a “strong-buy” rating in a report on Monday, May 18th. Two analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, National HealthCare has an average rating of “Buy”.

National HealthCare Trading Down 1.6%

NYSEAMERICAN NHC opened at $224.73 on Wednesday. The firm’s fifty day simple moving average is $217.84 and its two-hundred day simple moving average is $188.77. The firm has a market capitalization of $3.52 billion, a P/E ratio of 25.28 and a beta of 0.61. National HealthCare Corporation has a 12-month low of $110.83 and a 12-month high of $239.29.

National HealthCare (NYSEAMERICAN:NHC) last issued its quarterly earnings data on Thursday, August 6th. The company reported $1.74 EPS for the quarter. The firm had revenue of $408.03 million during the quarter. National HealthCare had a return on equity of 10.03% and a net margin of 9.00%.

National HealthCare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. National HealthCare’s dividend payout ratio is currently 61.89%.

Insider Transactions at National HealthCare

In other National HealthCare news, Director Lisa Piercey purchased 949 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was bought at an average cost of $184.26 per share, for a total transaction of $174,862.74. Following the completion of the purchase, the director owned 949 shares in the company, valued at $174,862.74. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Stephen Fowler Flatt sold 1,500 shares of the firm’s stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $237.08, for a total value of $355,620.00. Following the completion of the sale, the chief executive officer directly owned 65,487 shares of the company’s stock, valued at approximately $15,525,657.96. This represents a 2.24% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 13.92% of the company’s stock.

National HealthCare Company Profile

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.